The Journal of Nuclear Medicine Spotlights the Future of Nuclear Endocrinology

July 15, 2021

Reston, VA—The Journal of Nuclear Medicine (JNM) has published a special supplement highlighting molecular imaging advances in the field of endocrinology. The supplement focuses on the most novel approaches and cutting-edge clinical and scientific information regarding diagnostic nuclear imaging for several endocrine disorders, including thyroid disease, thyroid nodules, adrenal masses, congenital hyperinsulinism, pituitary adenomas, and more.

Nuclear medicine has always been an important component of endocrinology and continues to expand the understanding of endocrine diseases. Recent improvements in instrumentation and new radiopharmaceuticals have expanded the scope and use of nuclear endocrinology.

“The diversity of molecular targets uniquely expressed by endocrine tumors provides opportunities for enhanced characterization of these tumors with molecular imaging,” said David Taïeb, MD, PhD, JNM supplement editor. “Radiopharmaceuticals in endocrine applications serve not only as diagnostic agents, but also as a platform to treat patients with matched radionuclide therapy agents using a theranostic approach.”

Articles in the supplement include:

  • Primary Hyperparathyroidism: Defining the Appropriate Preoperative Imaging Algorithm
    Elif Hindié, Paul Schwartz, Anca M. Avram, Alessio Imperiale, Frederic Sebag and David Taïeb

  • Update on the Evaluation of Thyroid Nodules
    Victor J. Bernet and Ana-Maria Chindris

  • Molecular Imaging for Thyrotoxicosis and Thyroid Nodules
    Luca Giovanella, Anca Avram and Jerome Clerc

  • A Clinical Challenge: Endocrine and Imaging Investigations of Adrenal Masses
    Anders Sundin, Elif Hindié, Anca M. Avram, Antoine Tabarin, Karel Pacak and David Taïeb

  • Perspectives on Brown Adipose Tissue Imaging: Insights from Preclinical and Clinical Observations from the Last and Current Century
    John P. Crandall and Richard L. Wahl

  • Glucagon-like Peptide-1 Receptor as Emerging Target: Will It Make It to the Clinic?
    Damian Wild, Kwadwo Antwi, Melpomeni Fani and Emanuel R. Christ

  • 18F-6-Fluoro-L-Dopa PET/CT Imaging of Congenital Hyperinsulinism
    Lisa J. States, J. Christopher Davis, Steven M. Hamel, Susan A. Becker and Hongming Zhuang

  • Using Molecular Imaging to Enhance Decision Making in the Management of Pituitary Adenomas
    Waiel A. Bashari, Russell Senanayake, James MacFarlane, Daniel Gillett, Andrew S. Powlson, Angelos Kolias, Richard J. Mannion, Olympia Koulouri and Mark Gurnell

“The future for nuclear endocrinology is bright,” said JNM Editor-in-Chief Johannes Czernin, MD. “The clinical translation of new radiopharmaceuticals, together with PET technologic improvements, will lead to advances in the care of patients with endocrine disorders. This JNM supplement will be a helpful resource for practicing physicians in nuclear medicine, endocrinology and oncology as well as other healthcare professionals.”

The JNM supplement was created to be a resource for practicing physicians, including nuclear medicine specialists, radiologists, endocrinologists, and oncologists, as well as fellows in training, students, and other health care professionals. The supplement was edited by David Taïeb, MD, PhD, Elif Hindié, MD, PhD, and David Mankoff, MD, PhD.


The JNM Endocrinology Supplement is available at

Visit JNM’s new website for the latest research, and follow our new Twitter and Facebook pages @JournalofNucMed.


Please visit the 
SNMMI Media Center for more information about molecular imaging and precision imaging. For complimentary media access to articles or to schedule an interview with a researcher, please contact Rebecca Maxey at (703) 652-6772 or

About JNM and the Society of Nuclear Medicine and Molecular Imaging

The Journal of Nuclear Medicine (JNM) is the world’s leading nuclear medicine, molecular imaging and theranostics journal, accessed more than 11 million times each year by practitioners around the globe, providing them with the information they need to advance this rapidly expanding field. Current and past issues of The Journal of Nuclear Medicine can be found online at

JNM is published by the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit